European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: Practical guidance for use in patients at very high cardiovascular risk

  1. Landmesser, U.
  2. Chapman, M.J.
  3. Farnier, M.
  4. Gencer, B.
  5. Gielen, S.
  6. Hovingh, G.K.
  7. Lüscher, T.F.
  8. Sinning, D.
  9. Tokgözoǧlu, L.
  10. Wiklund, O.
  11. Zamorano, J.L.
  12. Pinto, F.J.
  13. Catapano, A.L.
Aldizkaria:
European Heart Journal

ISSN: 1522-9645,  0195-668X

Argitalpen urtea: 2017

Alea: 38

Zenbakia: 29

Orrialdeak: 2245-2255

Mota: Artikulua

DOI: 10.1093/EURHEARTJ/EHW480 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus